| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/29/2006 | CA2589764A1 Amide derivatives |
| 06/28/2006 | EP1674575A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674108A2 Osteoporosis treatment |
| 06/28/2006 | EP1673376A2 Treating bone-related disorders with selective androgen receptor modulators |
| 06/28/2006 | EP1673353A1 Transition state structure and inhibitors of thymidine phosphorylases |
| 06/28/2006 | EP1673345A1 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation |
| 06/28/2006 | EP1673336A1 Cathepsin cysteine protease inhibitors |
| 06/28/2006 | EP1562920B1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 06/28/2006 | EP1299088B1 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient |
| 06/28/2006 | EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 06/28/2006 | EP1255536B1 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2006 | EP1214452B1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 06/28/2006 | EP1140212B1 The use of radium-223 to target calcified tissues for pain palliation and therapy of bone cancer |
| 06/28/2006 | EP1121372B1 Adenine derivatives |
| 06/28/2006 | CN1795208A Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders |
| 06/28/2006 | CN1795005A Medicine health-care usage of globefish I collagen extration and preparing process thereof |
| 06/28/2006 | CN1794978A Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 06/28/2006 | CN1261431C 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 06/28/2006 | CN1261412C Indole derivatives as COXII inhibitors |
| 06/28/2006 | CN1261149C Medicine for treating rheumatoid arthritis, femur necrosis and ankylosing spondylitis |
| 06/28/2006 | CN1261139C Medicine for treating bone tuberculosis, osteomyelitis, synovitis and angiitis |
| 06/28/2006 | CN1261137C Chinese medicine preparation for treating traumatic injury |
| 06/28/2006 | CN1261136C Plaster of external use for lumbar and leg pain |
| 06/28/2006 | CN1261135C Medicine for curing rheumatism and traumatic injury |
| 06/28/2006 | CN1261134C Chinese medicine for treating bone injury disease and its preparing method |
| 06/28/2006 | CN1261133C Combination of medicine for curing rheumatism involiving bone and preparation method |
| 06/28/2006 | CN1261131C Medicinal plaster for treating cervical vertebra disease |
| 06/28/2006 | CN1261129C External used Chinese medicine plaster for removing obstruction in channel powder |
| 06/28/2006 | CN1261126C Medicine for treating bone and joint tuberculosis |
| 06/28/2006 | CN1261108C Chinese herbal medicinal composition for hyperosteogeny |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/27/2006 | US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 06/27/2006 | US7067619 Integrin-binding peptides |
| 06/27/2006 | US7067543 Anthranilic acid amides and pharmaceutical use thereof |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection |
| 06/27/2006 | US7067527 Thienopyridine derivatives, their production and use |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067514 Pyrimidine compounds |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/27/2006 | US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067480 Compositions and methods of use for anti-inflammatory agents |
| 06/27/2006 | US7067296 Enzymatic polypeptide for use in the treatment of pain, inflammation, arthritis, cancer and alzheimer's disease |
| 06/27/2006 | US7067285 Desaturase genes and uses thereof |
| 06/27/2006 | US7067154 Pharmaceutical compositions containing Vitamin D and calcium, their preparation and therapeutic use |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/24/2006 | CA2494575A1 Compositions and methods for the treatment of osteoporosis |
| 06/22/2006 | WO2006066067A2 Formulations of bisphosphonate drugs with improved bioavailability |
| 06/22/2006 | WO2006065975A2 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 06/22/2006 | WO2006065919A1 Pyridil-substituted spiro-hydantoin compounds and use thereof |
| 06/22/2006 | WO2006065908A1 Crystalline forms of6- [(5s, 9r) -9- (4-cyanophenyl) -3-(3, 5-dichlorophenyl) -1-methyl-2, 4-dioxo-1, 3, 7-triazaspiro [4.4] non-7-yl] nicotinic |
| 06/22/2006 | WO2006065216A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | WO2006065215A1 Novel compounds |
| 06/22/2006 | WO2006064886A1 Agent for regulating bone formation |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064381A2 Protein formulation |
| 06/22/2006 | WO2006064218A1 Hydantoin derivatives useful as metalloproteinase inhibitors |
| 06/22/2006 | WO2006063974A2 Il-15 antigen arrays and uses thereof |
| 06/22/2006 | WO2006063837A2 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 06/22/2006 | WO2006063762A1 Dipeptide nitriles |
| 06/22/2006 | WO2006063390A1 Osteoprotegerin variant proteins |
| 06/22/2006 | WO2006051314A3 Guanidine derivatives as inhibitors of ddah |
| 06/22/2006 | WO2005102362A8 Use of chondroitin sulphate e (cs-e ) for the treatment diseases or conditions related to collagen fibril formation. |
| 06/22/2006 | US20060136136 Crystal structure of baff, and use thereof in drug design |
| 06/22/2006 | US20060135842 Radiotherapy |
| 06/22/2006 | US20060135622 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 06/22/2006 | US20060135614 Novel compounds |
| 06/22/2006 | US20060135606 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 06/22/2006 | US20060135590 Selected fused pyrrolocarbazoles |
| 06/22/2006 | US20060135580 One step reaction of compound such as 3,5-dimethyl-isoxazole with butlyllithium and (3,5-di-tert-butyl)-4-hydroxybenzaldehyde, recrystallization/dehydration alcohol in the presence of a base to give (E)-5-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)vinyl]-3-methylisoxazole |
| 06/22/2006 | US20060135572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135508 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135493 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 06/22/2006 | US20060135492 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 06/22/2006 | US20060135469 Separate type medical material |
| 06/22/2006 | US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/22/2006 | US20060135407 Phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation |
| 06/22/2006 | US20060130852 Pharmaceutical kits comprising mesenchymal stem cells |
| 06/22/2006 | CA2767026A1 Protein formulation for administering an active enamel substance |
| 06/22/2006 | CA2591715A1 Agent for regulating bone formation |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2590845A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | CA2590843A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | CA2590778A1 Il-15 antigen arrays and uses thereof |
| 06/22/2006 | CA2590157A1 Solid forms of a chemokine receptor antagonist and methods of use thereof |
| 06/22/2006 | CA2589525A1 Hydantoin derivatives useful as metalloproteinase inhibitors |
| 06/22/2006 | CA2587932A1 Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy |
| 06/22/2006 | CA2587209A1 Osteoprotegerin variant proteins |
| 06/21/2006 | EP1671965A2 Oxacarbocyclic oligomers of fumaric acid |
| 06/21/2006 | EP1671962A1 Novel fused heterocyclic compound and use thereof |
| 06/21/2006 | EP1671641A1 Remedy and therapeutic method for periodontal diseases and pulpal diseases |
| 06/21/2006 | EP1671638A1 Disphosphonate solutions |